Advertisement

Advertisement

PLRZ Stock Latest News

Polyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway

Company AnnouncementsPolyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway

Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform

PremiumCompany Announcements

Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform

7d ago

Polyrizon receives notice of European patent publication

PremiumThe Fly

Polyrizon receives notice of European patent publication

7d ago

Polyrizon Secures Three Key U.S. Sites for NASARIX Allergy Trial

PremiumCompany Announcements

Polyrizon Secures Three Key U.S. Sites for NASARIX Allergy Trial

9d ago

Polyrizon Sets July 13, 2026 AGM to Vote on Board, Pay and Auditor Mandates

PremiumCompany Announcements

Polyrizon Sets July 13, 2026 AGM to Vote on Board, Pay and Auditor Mandates

9d ago

Polyrizon signs agreements with two additional clinical sites for Nasarix study

PremiumThe FlyPolyrizon signs agreements with two additional clinical sites for Nasarix study

9d ago

Polyrizon Extends Exclusivity on Proposed 51% Acquisition of Arrow Aviation

Company Announcements

Polyrizon Extends Exclusivity on Proposed 51% Acquisition of Arrow Aviation

12d ago

Polyrizon Appoints Veteran Entrepreneur Ami Oren to Board of Directors

Company Announcements

Polyrizon Appoints Veteran Entrepreneur Ami Oren to Board of Directors

21d ago

Polyrizon signs clinical trial agreement with clinical research site for Nasarix

PremiumThe Fly

Polyrizon signs clinical trial agreement with clinical research site for Nasarix

1M ago

Polyrizon Secures First U.S. Clinical Site for NASARIX Allergy Blocker Trial

PremiumCompany Announcements

Polyrizon Secures First U.S. Clinical Site for NASARIX Allergy Blocker Trial

1M ago

Polyrizon amends patent application claims for intranasal drug delivery platform

PremiumThe Fly

Polyrizon amends patent application claims for intranasal drug delivery platform

1M ago

Polyrizon Expands U.S. Patent Claims for Intranasal Drug Delivery Platform

PremiumCompany Announcements

Polyrizon Expands U.S. Patent Claims for Intranasal Drug Delivery Platform

1M ago

Polyrizon Ltd trading halted, volatility trading pause

PremiumThe FlyPolyrizon Ltd trading halted, volatility trading pause

2M ago

Polyrizon Ltd trading resumes

The Fly

Polyrizon Ltd trading resumes

2M ago

Polyrizon files European patent application for Trap & Target platform

The Fly

Polyrizon files European patent application for Trap & Target platform

2M ago

Polyrizon Files European Patent Application for Trap & Target Intranasal Drug Delivery Platform

PremiumCompany Announcements

Polyrizon Files European Patent Application for Trap & Target Intranasal Drug Delivery Platform

2M ago

Polyrizon files to sell 0.5M shares of common stock for holders

PremiumThe Fly

Polyrizon files to sell 0.5M shares of common stock for holders

2M ago

Polyrizon Raises $3.5 Million via Registered Direct Offering and Private Placement

PremiumCompany Announcements

Polyrizon Raises $3.5 Million via Registered Direct Offering and Private Placement

2M ago

Polyrizon to acquire 20% stake in Colugo for up to $6M

PremiumThe Fly

Polyrizon to acquire 20% stake in Colugo for up to $6M

3M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe FlyBiotech Alert: Searches spiking for these stocks today

3M ago

Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials

Company Announcements

Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials

3M ago

Polyrizon signs agreement with research organization for clinical development

The Fly

Polyrizon signs agreement with research organization for clinical development

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >